LENZ Therapeutics, Inc.
USD5.56
-0.20 (-3.47%)
CEO
Evert Schimmelpennink
IPO Date
2024-03-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.75
Prev. Close
$5.76
Day Low
$5.53
Day High
$5.84
52W Low
$5.23
52W High
$50.40
Market Cap
$0.17B
Volume
0.16M
| -12.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 75.5% | -99.4% | -0.00 | 3.63 | -1.4 |
| 31 Dec 2022 | FY | 100.0% | -72.1% | 44.7% | -23.0% | -0.01 | 4.91 | -11.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 497.8% | -385.9% | 0.00 | 14.62 | -6.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 697.7% | -303.0% | 0.00 | 0.66 | -10.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 4.9% | -1816.7% | -0.99 | 0.00 | -6665.0 |
| -3.5 |
| 30 Sept 2025 | Q3 | 99.0% | -133.6% | -8.6% | -7.9% | 0.00 | 12.69 | -19.9 |
| 30 Jun 2025 | Q2 | 99.6% | -298.2% | -7.2% | -6.9% | 0.01 | 20.54 | -13.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -7.6% | -7.3% | 0.01 | 23.09 | -12.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6.2% | -5.9% | 0.01 | 20.36 | -15.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -4.7% | -4.6% | 0.01 | 28.63 | -15.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -5.3% | -5.1% | 0.01 | 23.23 | -11.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -8.4% | -7.7% | 0.00 | 11.47 | -1.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 25.6% | -33.7% | -0.00 | 3.63 | -1.1 |